PYY3-36
Also called Peptide YY(3-36)
Intravenous (into a vein)Human study reference
Research reference
Human study
PYY3-36 food-intake experiment
Graded IV infusions during study visits
Food intake and symptoms around a study meal
Degen et al., Gastroenterology (2005) ↗When results may show
- When change was measured
- The study measured acute food intake and satiety, with nausea/fullness at higher exposure—not sustained weight loss.
- When to assess
- Food intake and symptoms around a study meal
- Conditions and limitations
- Human volunteers in a controlled infusion study. An acute IV appetite experiment supplies no weekly injection, nasal or home-use protocol.
- When to stop
- The measured study window is not a validated personal quit rule. Do not increase or prolong exposure because an expected result is absent; severe or persistent reactions need prompt clinical review.
Research timing is descriptive, not a promise or personal instruction. A severe or persistent reaction needs prompt clinical review. This is not medical advice.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 0.98× single dose
- Time to steady state
- 1hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Degen et al., Gastroenterology (2005)An acute IV appetite experiment supplies no weekly injection, nasal or home-use protocol.